← Back to Search

Healthy patients for Functional Abdominal Bloating

N/A
Recruiting
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1-4 years
Awards & highlights

Study Summary

We will sample intestinal microbiota using a microbiome sampling capsule in Healthy, Irritable Bowel Syndrome (IBS), and Functional Gastrointestinal Disease.

Eligible Conditions
  • Functional Abdominal Bloating
  • Healthy Subjects
  • Functional Gastrointestinal Disorders
  • Irritable Bowel Syndrome

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1-4 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1-4 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Collection of 50ul of intestinal fluid from >90% of microbiome sampling capsules
Secondary outcome measures
Isolation of liven bacteria from the intestinal fluid of >90% of microbiome sampling capsules

Trial Design

2Treatment groups
Experimental Treatment
Group I: IBS/Functional GI diaseaseExperimental Treatment1 Intervention
Patients with IBS or Functional GI disease (bloating, diarrhea, constipation)
Group II: Healthy patientsExperimental Treatment1 Intervention
Healthy Patients

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,387 Previous Clinical Trials
17,334,010 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~27 spots leftby Dec 2025